Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
AXLA
Axcella Health Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2019
Get push alerts for AXLA
Full AXLA profile on Quantisnow Follow AXLA and get a push notification the moment its next story breaks.